Assertio Holdings Acquired by Zydus Lifesciences | Healthcare M&A Deal

Zydus Lifesciences has agreed to acquire Assertio Holdings, a pharmacy business in Illinois, for $23.50 per share. Assertio Holdings is a healthcare company with operations tied to pharmaceutical products, supporting Zydus Lifesciences acquisitions in the pharmacy segment. Zydus Lifesciences acquisitions are structured as a merger acquisition through Zara Merger Sub Inc., targeting all outstanding common shares of Assertio Holdings acquisition. The healthcare M&A deal is a strategic acquisition by a strategic buyer, with deal size reported over $100M and an announced status.